Heme Protein Variants for Enantioselective Carbene C-H Insertion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for catalytic iron-carbene C—H insertion face challenges in site-selectivity and reactivity, particularly for sp3 C—H bonds, with existing catalysts often requiring elevated temperatures and resulting in non-selective reactions and limited synthetic utility.

Innovation Solution

Development of heme protein variants, such as cytochrome P450 enzymes with specific amino acid mutations, that catalyze enantio-, regio-, and chemo-selective intermolecular alkylation of sp3 C—H bonds using diazo compounds, enabling efficient and selective C—H functionalization.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If iron-porphyrin complexes are used for carbene C-H insertion at elevated temperatures, then the reaction can proceed, but site-selectivity is lost and non-selective product mixtures are formed

Engineering Contradiction:
Improvereaction activityVSAvoidsite-selectivity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The invention changes the temperature parameter from elevated temperatures (80-110°C) to ambient or lower temperatures, which fundamentally alters the reaction pathway. This parameter change allows the iron-carbene complex to remain stable and selective while still achieving productive C-H insertion, resolving the contradiction between activity and selectivity

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention introduces an intermediary mechanism where the iron-carbene complex is generated in situ at low temperatures and acts as a selective catalyst. This intermediary species mediates the reaction to achieve both high selectivity and activity, rather than relying on thermal activation of free carbene intermediates

Inventive Principle:
Principle #24Intermediary (Mediator)

2Manufacturing precision

If iron-phthalocyanine complexes are used for intramolecular sp3 C-H insertion, then the reaction proceeds with selectivity, but the synthetic utility is severely limited

Engineering Contradiction:
ImproveselectivityVSAvoidsynthetic utility
Core Design Contradiction:
Manufacturing precisionVSAdaptability or versatility

Solution Approach 1:

The invention creates a universal iron-containing catalyst system that can perform multiple functions: it catalyzes both intramolecular and intermolecular C-H insertions, works with various substrate types (benzylic, allylic, alkyl C-H bonds), and maintains high selectivity across different reaction contexts. This multi-functionality greatly expands synthetic utility while preserving selectivity

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Device complexity

If achiral catalysts are used for carbene C-H insertion, then the reaction is simple, but only racemic mixtures are formed

Engineering Contradiction:
Improvecatalyst complexityVSAvoidenantioselectivity
Core Design Contradiction:
Device complexityVSManufacturing precision

Solution Approach 1:

The invention introduces asymmetry into the catalyst system by using chiral ligands (such as P chiral ligands or chiral amino alcohols) coordinated to the iron center. This asymmetric environment in the catalyst translates to enantioselective C-H insertion, producing optically active products with high enantiomeric excess while maintaining catalytic efficiency

Inventive Principle:
Principle #4Asymmetry

4Adaptability or versatility

If the Fe-center in heme proteins is used for C-H insertion, then the catalyst is bio-compatible, but the reactivity is limited compared to Rh or Ir centers

Engineering Contradiction:
Improvebio-compatibilityVSAvoidreactivity
Core Design Contradiction:
Adaptability or versatilityVSProductivity

Solution Approach 1:

The invention changes the electronic and steric parameters of the iron center through ligand design. By using specialized ligands (porphyrins, phthalocyanines, or chiral ligands), the iron center's reactivity is tuned to match or exceed Rh/Ir catalysts while maintaining bio-compatibility. The ligand field strength and steric environment are optimized to enable productive C-H insertion at ambient temperatures

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention copies the successful reactivity patterns of Rh and Ir carbene complexes but implements them using an iron center. By studying the mechanisms of noble metal catalysts and replicating their key features with iron, the invention achieves comparable reactivity with the advantage of bio-compatibility and lower cost

Inventive Principle:
Principle #26Copying

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These heme protein variants achieve high turnover numbers and excellent enantioselectivity in functionalizing diverse alkanes, including benzylic and allylic C—H bonds, with up to thousands of total turnovers and >99:1 enantioselectivity, overcoming the limitations of previous catalysts.

Implementation Method 1

a heme protein comprising an iron porphyrin... under conditions sufficient to produce the C—H insertion product

Methodology Applied
Scientific EffectCatalysis: Catalysis

Implementation Method 2

enantioselective carbene C—H insertion using an iron-containing protein catalyst

Methodology Applied
Scientific EffectC-H insertion reaction: Chemical Bonding

Data Source

PatentUS10934531B2Method for enantioselective carbene C—H insertion using an iron-containing protein catalyst
Publication Date: 2021.03.02 CALIFORNIA INST OF TECH
  • US10934531B2 patent drawing
  • US10934531B2 patent drawing
  • US10934531B2 patent drawing

AI summary

Methods for catalyzing C—H insertion reactions using heme enzymes are described. The present disclosure provides a method for producing a C—H insertion product comprising providing an substrate having an sp3-hybridized C—H bond, a carbene precursor such as a diazo reagent, and a heme enzyme, and admixing the components in a reaction for a time sufficient to produce the C—H insertion product. Heme enzyme variants useful for carrying out in vivo and in vitro C—H insertion reactions, as well as expression vectors and host cells expressing the heme enzymes, are also described.